2FIRSTS | FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA authorized four more on! nicotine pouches, bringing the total to 30 and expanding its review pilot practices.Summary
The U.S. Food and Drug Administration (FDA) has authorized four additional nicotine pouch products from Helix Innovations LLC, under the on! brand, bringing the total number of authorized products to 30. These new products—Rich Berry 2 mg, Cappuccino 2 mg, Cappuccino 4 mg, and Autumn Spice 2 mg—expand Helix's authorized portfolio beyond the previously approved on! PLUS line.
These authorizations are a significant outcome of the FDA's nicotine pouch review pilot program, which tested more efficient communication and review methods. The agency has now decided to apply these streamlined practices to all nicotine pouch premarket tobacco product applications (PMTAs). This shift aims to improve efficiency while maintaining rigorous scientific standards.
Currently, the market for FDA-authorized nicotine pouches remains highly concentrated, with all 30 authorized products belonging to either Philip Morris International (via Swedish Match USA's ZYN brand) or Altria (via Helix Innovations). The FDA emphasizes that these authorizations do not imply the products are safe, but rather that they contain lower levels of harmful constituents than other tobacco products.
(Source：2Firsts)
